Analyzing Healthcare

In this episode of Analyzing Healthcare, Roy Bejarano sits down with Dr. Andrew von Eschenbach, former commissioner of the FDA, to discuss the evolution of healthcare, the challenges of regulation, and the future of medical innovation. They explore topics such as the FDA’s role in drug approvals, the integration of nutrition into healthcare policy, and how AI can revolutionize medical research. This is a must-listen for anyone interested in the intersection of healthcare, policy, and technology.

• [00:00] - Introduction to Dr. Andrew von Eschenbach and his journey to becoming FDA Commissioner
• [03:30] - The role of former commissioners in shaping healthcare policy
• [06:45] - Why the FDA remains the global gold standard for drug approvals
• [10:15] - The transformation of medicine through molecular research
• [19:00] - The FDA’s hidden vault of drug research and how AI can unlock its potential
• [25:00] - Food regulation and the role of nutrition in disease prevention
• [38:00] - Speed vs. safety: How the FDA can improve drug approval timelines
• [45:15] - The need for structural reforms at the FDA

• The FDA plays a crucial role in balancing innovation and safety, ensuring new drugs and medical devices reach the market efficiently without compromising public health.
• Food is a powerful medicine, and regulatory agencies must integrate nutritional science into healthcare policy to combat chronic diseases.
• AI and data analytics can revolutionize medical research, unlocking past studies and accelerating drug development.
• The FDA’s structure needs reform to eliminate inefficiencies and adapt to the rapid pace of scientific advancements.

Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Healthcare Innovations, Healthcare Industry Insights, U.S. Healthcare Policy, Dr. Andrew von Eschenbach, Analyzing Healthare the Podcast,

Andrew von Eschenbach, M.D., former FDA Commissioner and NCI Director, advanced regulatory science, streamlined drug approvals, and prioritized innovation in medical products. His leadership focused on cancer research, prevention, and improving public health outcome.

In this episode ofAnalyzing Healthcare, Roy Bejarano sits down with Dr. Andrew von Eschenbach, former commissioner of the FDA, to discuss the evolution of healthcare, the challenges of regulation, and the future of medical innovation. They explore topics such as the FDA’s role in drug approvals, the integration of nutrition into healthcare policy, and how AI can revolutionize medical research. This is a must-listen for anyone interested in the intersection of healthcare, policy, and technology.

Timestamps

• [00:00] Introduction to Dr. Andrew von Eschenbach and his journey to becoming FDA Commissioner
• [03:30] The role of former commissioners in shaping healthcare policy
• [06:45] Why the FDA remains the global gold standard for drug approvals
• [10:15] The transformation of medicine through molecular research
• [19:00] The FDA’s hidden vault of drug research and how AI can unlock its potential
• [25:00] Food regulation and the role of nutrition in disease prevention
• [38:00] Speed vs. safety: How the FDA can improve drug approval timelines
• [45:15] The need for structural reforms at the FDA

Key Takeaways:

• The FDA plays a crucial role in balancing innovation and safety, ensuring new drugs and medical devices reach the market efficiently without compromising public health.
• Food is a powerful medicine, and regulatory agencies must integrate nutritional science into healthcare policy to combat chronic diseases.
• AI and data analytics can revolutionize medical research, unlocking past studies and accelerating drug development.
• The FDA’s structure needs reform to eliminate inefficiencies and adapt to the rapid pace of scientific advancements.

Andrew von Eschenbach, M.D., former FDA Commissioner and NCI Director, advanced regulatory science, streamlined drug approvals, and prioritized innovation in medical products. His leadership focused on cancer research, prevention, and improving public health outcome.

Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Healthcare Innovations, Healthcare Industry Insights, U.S. Healthcare Policy, Dr. Andrew von Eschenbach, Analyzing Healthare the Podcast,

Roy Bejarano sits down with Rachel Winokur, CEO and Founder of TailorCare, to discuss how her risk-based musculoskeletal care model is reshaping patient-centered care. With a background in healthcare investment, payer strategy, and care delivery, Rachel shares her journey from Aetna and Bright Health to launching TailorCare, a company dedicated to optimizing MSK treatment pathways for better patient outcomes and lower costs.

This conversation dives into how care coordination, data-driven decision-making, and provider-patient engagement are essential for success in risk-based healthcare. Rachel also highlights the limitations of existing value-based models, the role of predictive analytics, and the future of innovative therapies like GLP-1s and stem cells.

• [00:01]  Introduction to Rachel Winokur and her career spanning Aetna, Bright Health, and TailorCare
• [04:47]  The evolution of risk-based musculoskeletal care and why it remains an untapped opportunity
• [08:12]  Challenges in Medicare Advantage and value-based models – misaligned financial incentives and fragmented care
• [14:36]  The importance of real-time data access and claims transparency in patient management
• [22:57]  How TailorCare’s risk-based navigation model improves patient outcomes and reduces unnecessary procedures
• [33:18]  The role of predictive analytics and provider quality data in care coordination
• [39:09]  How musculoskeletal care impacts patient mobility, function, and behavioral health[45:32] The potential impact of GLP-1s and stem cell therapies in orthopedic care

• Risk-Based Care Requires Smarter Coordination – TailorCare bridges payer incentives and provider decision-making to create cost-effective, high-quality MSK care pathways.
• Predictive Analytics is a Game Changer – Using claims data, patient history, and utilization patterns, TailorCare proactively navigates patients toward optimal treatment options.
• Care Fragmentation Leads to Poor Outcomes – Without structured guidance, MSK patients often go through unnecessary imaging, procedures, or delayed interventions, increasing costs and worsening health.
• Patients Need More Engagement & Support – TailorCare’s licensed physical therapists act as navigators, providing evidence-based guidance to ensure better outcomes and patient satisfaction.

Website: TailorCare

LinkedIn: Rachel Winokur

Rachel Winokur is a healthcare entrepreneur and executive with deep expertise in payer strategy, risk-based care models, and healthcare investment. She has led major initiatives at Aetna and Bright Health, driving value-based care adoption and primary care integration. As the Founder & CEO of TailorCare, she is revolutionizing musculoskeletal care by optimizing treatment pathways, improving patient engagement, and reducing unnecessary medical spend.

Healthcare, Patient-Centered Care, Healthcare Leadership, Roy Bejarano, Healthcare Innovations, Value-Based Care, Musculoskeletal Health, Risk-Based Models, Medicare Advantage, Care Coordination, Population Health, Digital Health, TailorCare, Healthcare Economics, Rachel Winokur

Roy Bejarano sits down with Rachel Winokur, CEO and Founder of TailorCare, to discuss how her risk-based musculoskeletal care model is reshaping patient-centered care. With a background in healthcare investment, payer strategy, and care delivery, Rachel shares her journey from Aetna and Bright Health to launching TailorCare, a company dedicated to optimizing MSK treatment pathways for better patient outcomes and lower costs.

This conversation dives into how care coordination, data-driven decision-making, and provider-patient engagement are essential for success in risk-based healthcare. Rachel also highlights the limitations of existing value-based models, the role of predictive analytics, and the future of innovative therapies like GLP-1s and stem cells.

Timestamps:

• [00:01]  Introduction to Rachel Winokur and her career spanning Aetna, Bright Health, and TailorCare
• [04:47]  The evolution of risk-based musculoskeletal care and why it remains an untapped opportunity
• [08:12]  Challenges in Medicare Advantage and value-based models – misaligned financial incentives and fragmented care
• [14:36]  The importance of real-time data access and claims transparency in patient management
• [22:57]  How TailorCare’s risk-based navigation model improves patient outcomes and reduces unnecessary procedures
• [33:18]  The role of predictive analytics and provider quality data in care coordination
• [39:09]  How musculoskeletal care impacts patient mobility, function, and behavioral health[45:32] The potential impact of GLP-1s and stem cell therapies in orthopedic care

Key Takeaways

• Risk-Based Care Requires Smarter Coordination – TailorCare bridges payer incentives and provider decision-making to create cost-effective, high-quality MSK care pathways.
• Predictive Analytics is a Game Changer – Using claims data, patient history, and utilization patterns, TailorCare proactively navigates patients toward optimal treatment options.
• Care Fragmentation Leads to Poor Outcomes – Without structured guidance, MSK patients often go through unnecessary imaging, procedures, or delayed interventions, increasing costs and worsening health.
• Patients Need More Engagement & Support – TailorCare’s licensed physical therapists act as navigators, providing evidence-based guidance to ensure better outcomes and patient satisfaction.

Website: TailorCare

LinkedIn: Rachel Winokur

About the Guest

Rachel Winokur is a healthcare entrepreneur and executive with deep expertise in payer strategy, risk-based care models, and healthcare investment. She has led major initiatives at Aetna and Bright Health, driving value-based care adoption and primary care integration. As the Founder & CEO of TailorCare, she is revolutionizing musculoskeletal care by optimizing treatment pathways, improving patient engagement, and reducing unnecessary medical spend.

Roy Bejarano sits down with Victor Schmerbeck, CEO of Emerus, to discuss the evolution of neighborhood hospitals, how health systems are shifting their care models, and the role of private equity in modernizing healthcare delivery.

In this episode, Victor explains how Emerus has partnered with 12 major health systems, developing 40+ neighborhood hospitals to improve patient access, care coordination, and efficiency. He shares insights on why hospitals are decentralizing, the financial structure of these partnerships, and why smaller hospitals reduce costs while improving outcomes. This discussion is essential for healthcare executives, payers, and investors looking to understand the future of hospital-at-home models, outpatient expansion, and MSO partnerships.

• [00:02] Introduction to Victor Schmerbeck and his leadership journey at Emerus
• [01:53]  The evolution of Emerus – from emergency care to health system partnerships
• [05:02]  Neighborhood hospitals vs. micro-hospitals – the shift to community-based care
• [12:56]  How neighborhood hospitals act as hubs, improving patient flow and referrals
• [18:17]  Why only 150+ neighborhood hospitals exist today and the case for expansion
• [24:46]  Hospitals are shifting towards performance-focused, cost-effective care
• [33:13]  The role of payers & value-based care in small-format hospital success
• [44:10]  How private equity supports hospital MSO partnerships and future growth

• Health Systems Are Decentralizing – Large hospitals are shifting to smaller, community-based neighborhood hospitals to increase access, lower costs, and improve care coordination.
• MSO-Hospital Partnerships Drive Efficiency – Through white-label partnerships, Emerus helps health systems operate efficient, high-quality neighborhood hospitals, reducing readmissions and length of stay.
• Neighborhood Hospitals Fill a Critical Gap – Positioned between urgent care and tertiary hospitals, these facilities reduce ER overcrowding and streamline specialty referrals.
• Private Equity Is Fueling Healthcare Innovation – Investors like Welsh Carson play a key role in funding operational improvements, driving focus, and expanding care models.

Website: Emerus



Victor Schmerbeck is the CEO of Emerus, the nation’s largest operator of neighborhood hospitals. With extensive experience in healthcare investment, operations, and system partnerships, he has led Emerus’ expansion to 40+ hospitals in collaboration with 12 major health systems. Under his leadership, Emerus has helped health systems increase access, reduce costs, and modernize acute care delivery.

Roy Bejarano sits down with Victor Schmerbeck, CEO of Emerus, to discuss the evolution of neighborhood hospitals, how health systems are shifting their care models, and the role of private equity in modernizing healthcare delivery.

In this episode, Victor explains how Emerus has partnered with 12 major health systems, developing 40+ neighborhood hospitals to improve patient access, care coordination, and efficiency. He shares insights on why hospitals are decentralizing, the financial structure of these partnerships, and why smaller hospitals reduce costs while improving outcomes. This discussion is essential for healthcare executives, payers, and investors looking to understand the future of hospital-at-home models, outpatient expansion, and MSO partnerships.

Timestamps

• [00:02] Introduction to Victor Schmerbeck and his leadership journey at Emerus
• [01:53]  The evolution of Emerus – from emergency care to health system partnerships
• [05:02]  Neighborhood hospitals vs. micro-hospitals – the shift to community-based care
• [12:56]  How neighborhood hospitals act as hubs, improving patient flow and referrals
• [18:17]  Why only 150+ neighborhood hospitals exist today and the case for expansion
• [24:46]  Hospitals are shifting towards performance-focused, cost-effective care
• [33:13]  The role of payers & value-based care in small-format hospital success
• [44:10]  How private equity supports hospital MSO partnerships and future growth

Key Takeaways

• Health Systems Are Decentralizing – Large hospitals are shifting to smaller, community-based neighborhood hospitals to increase access, lower costs, and improve care coordination.
• MSO-Hospital Partnerships Drive Efficiency – Through white-label partnerships, Emerus helps health systems operate efficient, high-quality neighborhood hospitals, reducing readmissions and length of stay.
• Neighborhood Hospitals Fill a Critical Gap – Positioned between urgent care and tertiary hospitals, these facilities reduce ER overcrowding and streamline specialty referral.
• Private Equity Is Fueling Healthcare Innovation – Investors like Welsh Carson play a key role in funding operational improvements, driving focus, and expanding care models.

Website: Emerus

About Victor Schmerbeck:

Victor Schmerbeck is the CEO of Emerus, the nation’s largest operator of neighborhood hospitals. With extensive experience in healthcare investment, operations, and system partnerships, he has led Emerus’ expansion to 40+ hospitals in collaboration with 12 major health systems. Under his leadership, Emerus has helped health systems increase access, reduce costs, and modernize acute care delivery.

In this episode of the Scale Community Technology & Innovation in Healthcare Series, host Jason Schifman sits down with Kyle Frye, CEO of Cortechs.ai, to discuss healthcare leadership and groundbreaking healthcare innovations in AI-powered imaging technology. Kyle shares how Cortechs.ai is revolutionizing brain care and oncology by introducing quantitative imaging, giving neurologists and radiologists the ability to track and analyze patient conditions like never before. Tune in to explore the healthcare trends shaping neuroimaging, AI in diagnostics, and the future of brain health.

• [02:00] – The evolution of Cortechs.ai from neurology to oncology: How AI is transforming healthcare industry insights.
• [05:30] – From black-and-white imaging to AI-driven data: The rise of quantitative imaging in healthcare leadership.
• [14:00] – Overcoming barriers to adoption: How AI-driven imaging integrates seamlessly with existing workflows.
• [22:45] – Case study: Using AI to detect traumatic brain injuries missed by traditional imaging.
• [32:30] – The future of preventative healthcare: Can AI-driven brain scans become as routine as blood tests?
• [42:00] – Expanding globally: How Cortechs.ai is bringing healthcare innovations to new markets.

• AI Enhances, Not Replaces, Radiology – Cortechs.ai provides neurologists and radiologists quantitative imaging that complements existing workflows, improving speed and accuracy.
• Data-Driven Brain Health is the Future – AI-based brain scans help detect dementia, tumors, and brain injuries earlier, improving healthcare industry insights and patient outcomes.
• Preventative Imaging is on the Rise – The adoption of full-body and brain scans as preventative healthcare trends is growing, potentially making AI-driven diagnostics routine.
• Global Expansion & Healthcare Accessibility – Cortechs.ai is working to improve imaging access worldwide, especially in regions where wait times for scans are long.

Website: https://www.cortechs.ai/

LinkedIn: https://www.linkedin.com/in/kyle-frye-18843119/

Kyle Frye, CEO of Cortechs.ai, a market leader, and innovator in medical technology solutions. Discover how the Company is transforming neurology, radiology, and oncology with state-of-the-art medical imaging, leveraging clinical data and machine learning to empower physicians in making more accurate and timely diagnostic decisions.

In this episode of the Scale Community Technology & Innovation in Healthcare Series, host Jason Schifman sits down with Kyle Frye, CEO of Cortechs.ai, to discuss healthcare leadership and groundbreaking healthcare innovations in AI-powered imaging technology. Kyle shares how Cortechs.ai is revolutionizing brain care and oncology by introducing quantitative imaging, giving neurologists and radiologists the ability to track and analyze patient conditions like never before. Tune in to explore the healthcare trends shaping neuroimaging, AI in diagnostics, and the future of brain health.

Timestamps:

• [02:00] – The evolution of Cortechs.ai from neurology to oncology: How AI is transforming healthcare industry insights.
• [05:30] – From black-and-white imaging to AI-driven data: The rise of quantitative imaging in healthcare leadership.
• [14:00] – Overcoming barriers to adoption: How AI-driven imaging integrates seamlessly with existing workflows.
• [22:45] – Case study: Using AI to detect traumatic brain injuries missed by traditional imaging.
• [32:30] – The future of preventative healthcare: Can AI-driven brain scans become as routine as blood tests?
• [42:00] – Expanding globally: How Cortechs.ai is bringing healthcare innovations to new markets.

Key Takeaways:

• AI Enhances, Not Replaces, Radiology – Cortechs.ai provides neurologists and radiologists quantitative imaging that complements existing workflows, improving speed and accuracy.
• Data-Driven Brain Health is the Future – AI-based brain scans help detect dementia, tumors, and brain injuries earlier, improving healthcare industry insights and patient outcomes.
• Preventative Imaging is on the Rise – The adoption of full-body and brain scans as preventative healthcare trends is growing, potentially making AI-driven diagnostics routine.
• Global Expansion & Healthcare Accessibility – Cortechs.ai is working to improve imaging access worldwide, especially in regions where wait times for scans are long.

Resources:

Website:https://www.cortechs.ai/

LinkedIn:https://www.linkedin.com/in/kyle-frye-18843119/

Kyle Frye, CEO of Cortechs.ai, a market leader, and innovator in medical technology solutions. Discover how the Company is transforming neurology, radiology, and oncology with state-of-the-art medical imaging, leveraging clinical data and machine learning to empower physicians in making more accurate and timely diagnostic decisions.

In this episode of the Scale Community Technology & Innovation in Healthcare Series, host Jason Schifman sits down with Bruno Piquin, CEO of Ensure Data Solutions, to discuss healthcare leadership, value-based care, and healthcare innovations in data analytics. With over 30 years of experience in the payer market, including roles at UnitedHealthcare, Humana, and Amerigroup, Bruno shares insights into healthcare industry trends, payer-provider collaboration, and how healthcare data analytics is reshaping the value-based care landscape. Learn how Ensure Data Solutions is providing healthcare industry insights that drive healthcare innovations for payers, providers, and ACOs.

• [00:00] Introduction to the podcast and guest, Bruno Piquin, CEO of Ensure Data Solutions
• [02:00] How data analytics is driving healthcare innovations and improving patient care
• [06:30] The impact of value-based care and shifting reimbursement models in the healthcare industry
• [12:00] Regulatory changes and their influence on healthcare trends
• [18:00] The role of interoperability and technology in healthcare leadership
• [30:00] Looking ahead: The future of healthcare industry insights and healthcare innovations



• Data analytics is revolutionizing healthcare leadership: Bruno Piquin highlights how Ensure Data Solutions helps providers navigate data complexity, improving patient care and financial outcomes in the healthcare industry.
• Value-based care is reshaping healthcare trends: The transition from fee-for-service to value-based models is changing the way providers and payers approach healthcare innovations.
• Regulatory shifts impact healthcare industry insights: New risk-adjustment policies and CMS guidelines are driving major changes, influencing the financial sustainability of the healthcare industry.
• Interoperability is key to healthcare leadership: The future of healthcare innovations relies on seamless data exchange between payers, providers, and healthcare technology platforms.

Resources:

Website: https://www.ensuredatasolutions.com/

LinkedIn: https://www.linkedin.com/in/bruno-piquin-3723741/

Bruno Piquin, a 25+ year executive in the healthcare payer and value-based care markets, and the current CEO of Ensure Data Solutions, a company that specializes in value-based care analytics

In this episode of the Scale Community Technology & Innovation in Healthcare Series, host Jason Schifman sits down with Bruno Piquin, CEO of Ensure Data Solutions, to discuss healthcare leadership, value-based care, and healthcare innovations in data analytics. With over 30 years of experience in the payer market, including roles at UnitedHealthcare, Humana, and Amerigroup, Bruno shares insights into healthcare industry trends, payer-provider collaboration, and how healthcare data analytics is reshaping the value-based care landscape. Learn how Ensure Data Solutions is providing healthcare industry insights that drive healthcare innovations for payers, providers, and ACOs.

Timestamps:

• [00:00] Introduction to the podcast and guest, Bruno Piquin, CEO of Ensure Data Solutions

• [02:00] How data analytics is driving healthcare innovations and improving patient care

• [06:30] The impact of value-based care and shifting reimbursement models in the healthcare industry

• [12:00] Regulatory changes and their influence on healthcare trends

• [18:00] The role of interoperability and technology in healthcare leadership

• • [30:00] Looking ahead: The future of healthcare industry insights and healthcare innovations

  
  

  Key Takeaways:

• Data analytics is revolutionizing healthcare leadership: Bruno Piquin highlights how Ensure Data Solutions helps providers navigate data complexity, improving patient care and financial outcomes in the healthcare industry.

• Value-based care is reshaping healthcare trends: The transition from fee-for-service to value-based models is changing the way providers and payers approach healthcare innovations.

• Regulatory shifts impact healthcare industry insights: New risk-adjustment policies and CMS guidelines are driving major changes, influencing the financial sustainability of the healthcare industry.

• Interoperability is key to healthcare leadership: The future of healthcare innovations relies on seamless data exchange between payers, providers, and healthcare technology platforms.

Resources:

Website: https://www.ensuredatasolutions.com/

LinkedIn: https://www.linkedin.com/in/bruno-piquin-3723741/

Bruno Piquin, a 25+ year executive in the healthcare payer and value-based care markets, and the current CEO of Ensure Data Solutions, a company that specializes in value-based care analytics.